AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Clinical trials for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA trials appear
Sign up with your email to follow new studies for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to soothe agitation in Alzheimer's patients
Symptom relief Recruiting nowThis study tests an experimental drug called ONO-2020 to see if it can safely reduce agitation in people with Alzheimer's disease. About 90 participants in Japan will receive either the drug or a placebo. The goal is to improve symptoms like restlessness and aggression without cu…
Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 17, 2026 07:11 UTC
-
New hope for Alzheimer's agitation: experimental drugs aim to soothe without sedation
Symptom relief Recruiting nowThis study tests two experimental drugs, EXV-802 and EXV-801, to see if they can safely reduce agitation in people with Alzheimer's disease. About 300 participants aged 55 to 90 with moderate to severe agitation will receive either the drug or a placebo for 6 weeks. The goal is t…
Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Phase: PHASE2, PHASE3 • Sponsor: Exciva GmbH • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC